Novavax

YTD

ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.

CEO

John C.s Jacobs

CEOJohn C.s Jacobs

Employees

749

Employees749

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1987

Founded1987

Employees

749

Employees749

NVAX Key Statistics

Market cap

1.87B

Market cap1.87B

Price-Earnings ratio

-7.43

Price-Earnings ratio-7.43

Dividend yield

—

Dividend yield—

Average volume

8.24M

Average volume8.24M

High today

$11.75

High today$11.75

Low today

$10.90

Low today$10.90

Open price

$11.01

Open price$11.01

Volume

4.96M

Volume4.96M

52 Week high

$13.39

52 Week high$13.39

52 Week low

$6.20

52 Week low$6.20

Stock Snapshot

The current Novavax(NVAX) stock price is $11.33, with a market capitalization of 1.87B. The stock trades at a price-to-earnings (P/E) ratio of -7.43.

As of 2026-10-07, Novavax(NVAX) stock has fluctuated between $10.90 and $11.75. The current price stands at $11.33, placing the stock +3.9% above today's low and -3.6% off the high.

The Novavax(NVAX)'s current trading volume is 4.96M, compared to an average daily volume of 8.24M.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $13.39 at its peak.

NVAX News

Benzinga 7h

Transcript: Novavax Q2 2026 Earnings Conference Call - Benzinga

...

TipRanks 22h

Novavax Stock Plunges After WHO Calms Plague Fears

Shares of vaccine developer Novavax (NVAX) plunged on Tuesday after the World Health Organization said that the risk of a wider plague outbreak remains low. The...

Benzinga 1d

Novavax Stock Falls Back: What's Going On?

Novavax Inc. (NASDAQ:NVAX) shares are pulling back Tuesday after a more than 20% surge Monday. Vaccine stocks rallied after a suspected pneumonic plague case in...

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

14.3%

Sell

28.6%

More NVAX News

Simply Wall St 2d

Novavax Stock Looks Fully Priced On Its Current Sales Base

has seen sharp swings in investor sentiment over the past few years, yet the latest share price level raises a straightforward question. Given where the stock t...

Benzinga 2d

Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety

Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDAQ:PCVX) and Novavax Inc. (NASDAQ:NVAX) are moving in the after...

Benzinga 2d

Novavax Shorts on Edge as Russia Plague Fears Spread

A suspected plague death at a Siberian research institute has investors reaching for the pandemic playbook again. One of biotech’s most heavily shorted stocks i...

24/7 Wall St. 2d

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Investing Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up Sanofi just handed Novavax a commercial li...

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.